Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques. (Q33578049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Karl Ljungberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Peter Liljeström

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

David A Price

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Andrew James McMichael

11

object named as

Andrew J McMichael

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Cornelis J. M. Melief

20

object named as

Cornelis J M Melief

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

15

Daniel C Douek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

5

Brenna J Hill

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

12

Jan W Drijfhout

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Maximillian Rosario

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Esther D Quakkelaar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Maire F Quigley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Maria L Knudsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Virginia Ammendola

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Nicola Borthwick

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Eung-Jun Im

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Hui Yee Greenaway

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Vanessa Venturi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Stefano Colloca

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Alfredo Nicosia

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Tomás Hanke

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

1973-1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20468055%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

cites work

Toward an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Design and pre-clinical evaluation of a universal HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Different Vaccine Vectors Delivering the Same Antigen Elicit CD8+ T Cell Responses with Distinct Clonotype and Epitope Specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

CD8+ T cell cross-priming via transfer of proteasome substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Cellular protein is the source of cross-priming antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Antigen bias in T cell cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

21 January 2018

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV inf

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Diversity considerations in HIV-1 vaccine selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

STEP trial and HIV-1 vaccines inducing T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Extraction and characterization of the rhesus macaque T-cell receptor beta-chain genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Correlation between viral RNA levels but not immune responses in plasma and tissues of macaques with long-standing SIVmac251 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

T Cell Receptor Recognition Motifs Govern Immune Escape Patterns in Acute SIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

inferred from DOI database lookup

7 January 2021

based on heuristic

Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344

inferred from DOI database lookup

7 January 2021

based on heuristic

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201040344